Brainstorm Cell Therapeutics Inc (OQ:BCLI)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BCLI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 1/20 Polverino Anthony J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,071  
Dec 27/19 Dec 24/19 Kern Ralph Dr. Direct Ownership Common Stock P - Open market or private purchase 3,000 $3.88
Dec 27/19 Dec 24/19 Shah Preetam Direct Ownership Common Stock P - Open market or private purchase 11,600 $3.96
Dec 27/19 Dec 24/19 Araya Arturo Direct Ownership Common Stock P - Open market or private purchase 3,000 $3.90
Feb 14/20 Dec 12/19 Yablonka Uri Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 13,333  
Feb 14/20 Dec 12/19 Arbel Irit Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 25,333  
Feb 14/20 Dec 12/19 Polverino Anthony J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,000  
Feb 14/20 Dec 12/19 Almenoff June Sherie Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,000  
Feb 14/20 Dec 12/19 Taub Malcolm S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 12,000  
Sep 9/19 Sep 6/19 Shah Preetam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BCLI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Dec 12/19 Yablonka Uri Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 13,333  
Feb 14/20 Dec 12/19 Arbel Irit Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 25,333  
Feb 14/20 Feb 1/20 Polverino Anthony J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,071  
Feb 14/20 Dec 12/19 Polverino Anthony J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,000  
Feb 14/20 Dec 12/19 Almenoff June Sherie Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,000  
Feb 14/20 Dec 12/19 Taub Malcolm S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 12,000  
Dec 27/19 Dec 24/19 Kern Ralph Dr. Direct Ownership Common Stock P - Open market or private purchase 3,000 $3.88
Dec 27/19 Dec 24/19 Shah Preetam Direct Ownership Common Stock P - Open market or private purchase 11,600 $3.96
Dec 27/19 Dec 24/19 Araya Arturo Direct Ownership Common Stock P - Open market or private purchase 3,000 $3.90
Sep 9/19 Sep 6/19 Shah Preetam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BCLI

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Alnylam Pharmaceuticals (OQ:ALNY)